Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05307822 · ClinicalTrials.gov registry record · NA
CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting
A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 7
- Study locations
NCT05307822: Completed NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.
NCT05307822 is a NA study of Smoking and Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 194 participants, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (57% lower). The trial reports 7 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05307822, a NA study of Smoking and Tobacco Use, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a multi-center, open-label, parallel-cohort-study to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) combustible cigarette (CC) and/or a UB Heated Tobacco Product (HTP) to one of four investigational products (IPs), across two heating modes, over a 28-day ambulatory period.
Primary Outcome
Arithmetic Mean puff duration across the final 14 days of data collection
Conditions Studied
Interventions
- OTHER Non-combusted cigarette variant 42001401
- OTHER Non-combusted cigarette variant 42001399
- OTHER Non-combusted cigarette variant 40007386
- OTHER Non-combusted cigarette variant 42001402
Study Locations (7)
North Carolina
- Rose Research Center - Charlotte
- High Point Clinical Trials Center - High Point
- Rose Research Center - Raleigh
Texas
- Benchmark Research - Fort Worth
- Benchmark Research - San Angelo
Georgia
- Wake Research (MTVCR) - Sandy Springs
Kentucky
- AMR Lexington - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2022-11-11 |
| Phase | NA |
What the finished NCT05307822 record still lists
NCT05307822 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (57% lower).
The record links to 4 conditions, with Smoking appearing as the primary indexed condition, and to 4 interventions - of which Non-combusted cigarette variant 42001401 is the first listed.
NCT05307822 lists 7 locations in 4 states (North Carolina, Texas, Georgia).
Frequently Asked Questions
What is clinical trial NCT05307822 about?
NCT05307822 is a clinical study titled "CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting". This is a multi-center, open-label, parallel-cohort-study to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) combustible cigarette (CC) and/or a UB Heated Tobacco Product (HTP) to one of four investigational products (IPs), across two he...
What is the current status of trial NCT05307822?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2022-04-21. Estimated completion is 2022-11-11.
What conditions does trial NCT05307822 study?
This clinical trial studies the following conditions: Smoking, Tobacco Use, Tobacco Smoking, Smoking Behaviors.
What interventions are being tested in trial NCT05307822?
The interventions under investigation include: Non-combusted cigarette variant 42001401 (OTHER), Non-combusted cigarette variant 42001399 (OTHER), Non-combusted cigarette variant 40007386 (OTHER), Non-combusted cigarette variant 42001402 (OTHER).
Who is sponsoring clinical trial NCT05307822?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05307822 being conducted?
This trial has 7 study locations across Georgia, Kentucky, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05307822's enrollment target sits among peer trials
194 59th of 123 higher than 65 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI